Monitor for any subsequent management restructuring or changes in commercial strategy; the redistribution of CCO responsibilities may signal organizational shifts but no immediate catalyst.
Price Chart
Executive Summary
HealthEquity terminated Chief Commercial Officer Michael Fiore without cause, effective October 5, 2026. His responsibilities will be redistributed to other management team members. This is a routine officer departure with no financial details disclosed and no replacement named, indicating limited immediate impact.
Key Facts
- Michael Fiore, Chief Commercial Officer, terminated without cause effective October 5, 2026
- Responsibilities to be redistributed to other management team members
- Severance payments and benefits per previously filed employment agreement and proxy statement
- Outstanding equity awards treated per existing stock incentive plans and award agreements
- No replacement named
Financial Impact
Severance payments and equity treatment per existing agreements; no specific dollar amounts disclosed
Risk Factors
- Potential disruption to commercial operations during transition period
- No successor named, which may create temporary leadership gap
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-115084 |
| Document: 0001104659-26-115084-index-headers.html | 0001104659-26-115084 |
| Document: 0001104659-26-115084-index.html | 0001104659-26-115084 |
| Document: 0001104659-26-115084.txt | 0001104659-26-115084 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 5d ago | Institutional Cluster | $100.88 | awaiting T+20 | awaiting T+20 | $102.47 (+1.58%) |
Oct 19, 2026 12d ago | Insider Cluster | $96.60 | awaiting T+20 | awaiting T+20 | $102.47 (+6.08%) |
Oct 9, 2026 22d ago | 8-K | $92.03 | awaiting T+20 | awaiting T+20 | $102.47 (+11.34%) |
Oct 9, 2026 23d ago | SC 13G/A | $92.61 | awaiting T+20 | awaiting T+20 | $102.47 (+10.65%) |
Oct 8, 2026 23d ago | 144 | $92.61 | awaiting T+20 | awaiting T+20 | $102.47 (+10.65%) |
Oct 8, 2026 23d ago | 144 | $92.61 | awaiting T+20 | awaiting T+20 | $102.47 (+10.65%) |
Oct 8, 2026 23d ago | 144 | $92.61 | awaiting T+20 | awaiting T+20 | $102.47 (+10.65%) |
Oct 8, 2026 23d ago | 144 | $92.61 | awaiting T+20 | awaiting T+20 | $102.47 (+10.65%) |
Oct 8, 2026 23d ago | 144 | $92.61 | awaiting T+20 | awaiting T+20 | $102.47 (+10.65%) |
Oct 8, 2026 23d ago | 144 | $92.61 | awaiting T+20 | awaiting T+20 | $102.47 (+10.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers